Maria Caterina P.
- Country
- Italy
- Department
- UOC Oncoematologia Pediatrica
Research Overview
- International Pediatric Study of Arsenic Trioxide and Tretinoin ± Gemtuzumab Ozogamicin for Acute Promyelocytic Leukemia in Children and Adolescents
- Phase 3 Study of Imatinib with Cytotoxic Chemotherapy in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Evaluation of Bortezomib, Blinatumomab, and Methotrexate in Pediatric Acute Lymphoblastic Leukemia: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 147 of 224 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in treating acute lymphoblastic leukemia, with particular expertise in managing complex cases involving Philadelphia chromosome-positive ALL.
- Pediatric Leukemia Treatment
- Adolescent Cancer Care
- Genetic Leukemia Variants
The investigator's work encompasses comprehensive treatment approaches for various risk classifications in leukemia patients.
Therapeutic Innovation
Focus areas include developing treatment protocols incorporating targeted molecular therapies and immunotherapy approaches for leukemia management.
- Risk-Adapted Treatment Strategies
- Combination Therapy Protocols
- Treatment Response Assessment
The investigator evaluates innovative therapeutic combinations to enhance treatment outcomes in challenging leukemia cases.
Clinical Advancement
Expertise in developing personalized treatment protocols based on genetic markers and response-guided therapy for pediatric and adolescent patients.
- Disease-Free Survival Optimization
- Risk Stratification Approaches
- Treatment Response Monitoring
The investigator implements sophisticated treatment strategies incorporating both established and novel therapeutic agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.